CHARACTERISTICS OF CARDIAC ARRHYTHMIAS ON 24-HOUR HOLTER ELECTROCARDIOGRAM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Văn Thường Bùi , Song Giang Trần, Hữu Tuyển Nguyễn

Main Article Content

Abstract

Objectives: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease characterized by myocardial hypertrophy, which may lead to varying degrees of left ventricular outflow tract obstruction. One of the most frequent and potentially life-threatening complications of HCM is cardiac arrhythmia. This study aimed to describe the characteristics of cardiac arrhythmias detected by 24-hour Holter electrocardiography and to investigate several factors associated with arrhythmias in patients with hypertrophic cardiomyopathy at the Vietnam National Heart Institute, Bach Mai Hospital. Methods: A cross-sectional case-series study was conducted from October 2023 to February 2025, including 39 patients diagnosed with hypertrophic cardiomyopathy at Bach Mai Hospital. Results: Among the 39 HCM patients enrolled in the study, the most common arrhythmia was premature ventricular contractions, observed in 61.5% (24/39) of patients. Atrial fibrillation was present in 38.46% (15/39), ventricular tachycardia in 17.95% (7/39), and atrial tachycardia in 5.13% (2/39) of patients. In HCM patients with atrial fibrillation, left atrial diameter, left ventricular end-diastolic diameter, and the proportion of patients with left ventricular ejection fraction <40% were significantly higher compared with those without atrial fibrillation (p < 0.05). The prevalence of systolic anterior motion (SAM) was significantly higher in patients with premature ventricular contractions than in those without premature ventricular contractions (p = 0.01). Conclusions: Cardiac arrhythmias are common in patients with hypertrophic cardiomyopathy, with premature ventricular contractions and atrial fibrillation being the two most frequently observed arrhythmias.

Article Details

References

1. Kocovski L, Fernandes J. Sudden cardiac death: a modern pathology approach to hypertrophic cardiomyopathy. Archives of Pathology and Laboratory Medicine. 2015;139(3):413-416.
2. Du et al. Journal of Cardiothoracic Surgery (2023) 18:196
3. Moon I, Lee S-Y, Kim H-K, et al. Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study. PloS one. 2020;15(1):e0227012.
4. Ayoub C, Geske JB, Larsen CM, Scott CG, Klarich KW, Pellikka PA. Comparison of Valsalva maneuver, amyl nitrite, and exercise echocardiography to demonstrate latent left ventricular outflow obstruction in hypertrophic cardiomyopathy. The American Journal of Cardiology.
5. Đặng Thị Linh, Nguyễn Thị Thu Hoài, Mai Trung Anh và Đặng Thị Linh, Nguyễn Thị Thu Hoài, Phạm Mạnh Hùng 2023. Khảo sát sức căng thất trái bằng siêu âm đánh dấu mô cơ tim ở bệnh nhân bệnh cơ tim phì đại. Tạp chí Tim mạch học Việt Nam. 2023,96, 43–51.
6. Y Tezuka, K Doi, Y Hamatani, Y An, M Ishii, M Iguchi, N Masunaga, M Esato, H Wada, K Hasegawa, H Ogawa, M Abe, M Akao, Association of left ventricular end-diastolic diameter with incidence of thromboembolism in patients with non-valvular atrial fibrillation: the Fushimi AF Registry, European Heart Journal, Volume 42, Issue Supplement_1, October 2021.
7. Kubo, T, Kitaoka, H, Yamanaka, S. et al. Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy. JACC. 2013 Oct, 62 (14) 1252–1259.